🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety, tolerability, and pharmacokinetics of single and mu...
Status
Terminated
Location
PPD Development, LP
Start Date
2015-07-17
Trial ID
NCT02502188
This will be a FTIH study which aims to evaluate safety, tolerability, phar...
Status
Terminated
Location
GSK Investigational Site
Start Date
2021-09-20
Trial ID
NCT05044325
Treatments Being Tested
The principal aim of this study is to obtain safety and tolerability data w...
Status
Active Not Recruiting
Location
Clinical Pharmacology of Miami, LLC
Start Date
2025-06-27
Trial ID
NCT07119125
In this study, researchers are learning more about RTA 408, also known as o...
Status
Completed
Location
UCLA
Start Date
2015-01-31
Trial ID
NCT02255435
The purpose of the study is to investigate the mechanism of action for lige...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2020-08-05
Trial ID
NCT04513548
Treatments Being Tested
The primary purpose of this study is to assess the safety and tolerability ...
Status
Completed
Location
ICON 1255 East 3900 South
Start Date
2024-02-20
Trial ID
NCT06286033
The aim of this study is to evaluate the efficacy and safety of GDC-8264 co...
Status
Terminated
Location
University of Stanford Medical Center
Start Date
2025-01-17
Trial ID
NCT06602453
This study is being conducted to assess the plasma CTx-1 concentrations whe...
Status
Completed
Location
Bio-Kinetic Clinical Applications, Inc.
Start Date
2008-12
Trial ID
NCT00803686
Treatments Being Tested
This three-part study will evaluate the pharmacokinetics and bioavailabilit...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01654211
Treatments Being Tested
This Phase 1, first-in-human, randomized, double-blinded, placebo controlle...
Status
Unknown
Location
Medpace Clinical Pharmacology Unit
Start Date
2022-11-16
Trial ID
NCT05650112